Literature DB >> 10989256

Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic Consensus Conference 2000.

G Bennett1, K Burchiel, E Buchser, A Classen, T Deer, S Du Pen, F M Ferrante, S J Hassenbusch, L Lou, J Maeyaert, R Penn, R K Portenoy, R Rauck, M Serafini, K D Willis, T Yaksh.   

Abstract

Consensus guidelines developed by an expert panel are helpful to clinicians when there is variation in practice and lack of a firm evidence base for an intervention, such as intraspinal therapy for pain. An internet-based survey of practitioners revealed remarkable variation in practice patterns surrounding intraspinal therapy. This prompted an interdisciplinary panel with extensive clinical experience in intraspinal infusion therapy to evaluate the results of the survey, the systematic reviews of the literature pertaining to this approach, and their own clinical experience with long-term spinal infusions. The panel proposed a scheme for the selection of drugs and doses for intraspinal therapy, and suggested guidelines for administration that would increase the likelihood of a successful outcome. These expert panel guidelines were designed to provide an initial structure for clinical decision making that is based on the best available evidence and the perspectives of experienced clinicians.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989256     DOI: 10.1016/s0885-3924(00)00202-5

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  14 in total

1.  [Withdrawal in a patient with an implantable drug delivery system in spite of continuation of opiate therapy].

Authors:  S Lochner; U Heinrich-Gräfe; W Kirch
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

Review 2.  [Importance of intrathecal pain therapy].

Authors:  R Likar; W Ilias; H Kloimstein; A Kofler; H G Kress; J Neuhold; M M Pinter; M C Spendel
Journal:  Schmerz       Date:  2007-02       Impact factor: 1.107

Review 3.  Current developments in intraspinal agents for cancer and noncancer pain.

Authors:  Erin F Lawson; Mark S Wallace
Journal:  Curr Pain Headache Rep       Date:  2010-02

Review 4.  Intraspinal techniques for pain management in cancer patients: a systematic review.

Authors:  Jeff Myers; Vincent Chan; Virginia Jarvis; Cindy Walker-Dilks
Journal:  Support Care Cancer       Date:  2010-02       Impact factor: 3.603

Review 5.  Complex regional pain syndrome: a review of evidence-supported treatment options.

Authors:  E Daniela Hord; Anne Louise Oaklander
Journal:  Curr Pain Headache Rep       Date:  2003-06

6.  [Neurological complications and loss of efficacy with intrathecal pain therapy].

Authors:  D Kindler; C Maier; T Kagel; S Schulz; T Weiss; M Zenz
Journal:  Schmerz       Date:  2005-04       Impact factor: 1.107

7.  Unique Intradural Inflammatory Mass Containing Precipitated Morphine: Confirmatory Analysis by LESA-MS and MALDI-MS.

Authors:  Alexander J Kim; Sankha Basu; Carolyn Glass; Edgar L Ross; Nathalie Agar; Qing He; David Calligaris
Journal:  Pain Pract       Date:  2018-03-30       Impact factor: 3.183

Review 8.  Neuraxial pain relief for intractable cancer pain.

Authors:  Paul A Sloan
Journal:  Curr Pain Headache Rep       Date:  2007-08

Review 9.  Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.

Authors:  David S Hersh; Aniket S Wadajkar; Nathan Roberts; Jimena G Perez; Nina P Connolly; Victor Frenkel; Jeffrey A Winkles; Graeme F Woodworth; Anthony J Kim
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

10.  Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain.

Authors:  Howard S Smith; Timothy R Deer
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.